Ayush Ministry Gets Rs 3,712 Crore In Interim Budget

New Delhi: The interim Budget allocation for the Ayush Ministry has been increased to Rs 3,712.49 crore for 2024-25 from Rs 3,000 crore (revised estimates) in 2023-24, recording a rise of 23.74 percent.

The National Medicinal Plants Board has been allocated Rs 14.63 crore while the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) allocated Rs 20.80 crore.

The autonomous bodies have been allocated Rs 1,848.40 crore, of which Central Council for Research in Ayurvedic Sciences has been given Rs 413.54 crore, Central Council for Research in Homeopathy Rs 144 crore, Central Council for Research in Unani Medicine Rs 228.05 crore and the All India Institute of Ayurveda has got Rs 227.20 crore.

The National Medicinal Plants Board undertakes promotional and contractual farming schemes with a view to encourage in-situ conservation and ex-situ cultivation of medicinal plants for providing raw materials of assured quality for manufacturing of ASU&H medicines.

At the initiative of the National Medicinal Plants Board, 32 State Medicinal Plants Boards in 27 states and five Union territories have been constituted for providing impetus to cultivation of high priority medicinal plants for domestic consumption as well as export.

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy is a subordinate office under the Ministry of Ayush. It is an appellate authority for drug testing of all Ayush drugs in India. Further, it sets standards for all Ayush drugs which are published in the form of Pharmacopoeias.

Related Posts

  • Pharma
  • June 17, 2025
  • 93 views
Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

  • Pharma
  • June 17, 2025
  • 96 views
Zydus Healthcare appoints Swati Dalal MD

Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco API plant gets one observation from FDA

Natco API plant gets one observation from FDA